Peptide record

TPDB66690

ACE inhibitor ACE inhibitors standard
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB66690
ACE inhibitor
ACE inhibitors
Cardiometabolic peptides
Peptipedia
standard
No
A 6-aa standard natural ace inhibitors peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
VVYPWR
Physicochemical Analysis
C41H58N10O8
ANDCEQGHILKMFST
V
818.97
9.88
1
0
4
+1
-1.39
0.017
96.67
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
6990
853.51
1
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
1
P
0
S
0
T
1
W
1
Y
2
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 1 S: 0 T: 0 W: 1 Y: 1 V: 2
Chemical Descriptors
6
C41H58N10O8
818.97
9.88
+1
-1.39
0.017
818.9591
818.4426
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
5.22 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Aiemratchanee P., Panyawechamontri K., Phaophu P., Reamtong O., Panbangred W.
In vitro antihypertensive activity of bioactive peptides derived from porcine blood corpuscle and plasma proteins. Int. J. Food Sci. Technol., 56, 2315–2324, 2021
2021
Journal

Other

6
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC3=C[N]([H])C4=CC=CC=C34)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O InChI=1S/C41H58N10O8/c1-22(2)33(42)37(55)50-34(23(3)4)38(56)49-31(19-24-13-15-26(52)16-14-24)39(57)51-18-8-12-32(51)36(54)48-30(20-25-21-46-28-10-6-5-9-27(25)28)35(53)47-29(40(58)59)11-7-17-45-41(43)44/h5-6,9-10,13-16,21-23,29-34,46,52H,7-8,11-12,17-20,42H2,1-4H3,(H,47,53)(H,48,54)(H,49,56)(H,50,55)(H,58,59)(H4,43,44,45)/t29-,30-,31-,32-,33-,34-/m0/s1 InChIKey=CISJINXSPQBNFJ-CVUOCSEZSA-N
Additional Detail Fields 1 fields
6